Physician profile
Ajit N Kumar
NPI 1609818558
$481.55
in general payments reported to CMS, 2019-2025
7 companies · $58.02 in 2025
The $58.02 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $14.42 · 2022: $83.94 · 2023: $83.92 · 2024: $32.95 · 2025: $58.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.08 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $161.65 | 2019-2025 | Bridion |
| Edwards Lifesciences Corporation | $124.35 | 2019-2024 | Hemosphere |
| Pacira Pharmaceuticals Incorporated | $90.81 | 2019 | |
| Becton, Dickinson and Company | $43.18 | 2025 | |
| Boston Scientific Corporation | $28.26 | 2022 | |
| Pajunk Medical Systems, Lp | $20.91 | 2023 | E-Cath Plus Acc. Tsui |
| Stryker Corporation | $12.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajit Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.